These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8249722)

  • 21. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
    J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic changes related to different types of hormonal therapies.
    Pongsatha S; Muttarak M; Chaovisitseree S; Luewan S; Panpanit A
    J Med Assoc Thai; 2006 Feb; 89(2):123-9. PubMed ID: 16578996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
    Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of mammography in the diagnosis and management of breast disease in postmenopausal women.
    Lamas AM; Horwitz RI; Peck D
    JAMA; 1984 Dec; 252(21):2999-3002. PubMed ID: 6502862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of estrogen-progestin and estrogen on mammographic density.
    Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
    J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mammography changes associated with hormone replacement therapy in post-menopausal patients].
    Del Favero C; Rossini G; Tufarulo L; Ciancio ML; Sopransi M; Martegani A; Borghi C; Campi R; Fugazzola C
    Radiol Med; 1997 Mar; 93(3):210-3. PubMed ID: 9221411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Milk of calcium within tiny benign breast cysts.
    Sickles EA; Abele JS
    Radiology; 1981 Dec; 141(3):655-8. PubMed ID: 7302218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
    Stomper PC; Van Voorhis BJ; Ravnikar VA; Meyer JE
    Radiology; 1990 Feb; 174(2):487-90. PubMed ID: 2136958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT appearance of the normal and abnormal breast with mammographic correlation.
    Goldberg PA; White CS; McAvoy MA; Templeton PA
    Clin Imaging; 1994; 18(4):262-72. PubMed ID: 8000953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prolactin levels are positively associated with mammographic density in postmenopausal women.
    Greendale GA; Huang MH; Ursin G; Ingles S; Stanczyk F; Crandall C; Laughlin GA; Barrett-Connor E; Karlamangla A
    Breast Cancer Res Treat; 2007 Nov; 105(3):337-46. PubMed ID: 17260098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specificity and sensitivity of mammographic screening.
    Patella A; Marziani R; Schippa A; Benedetti S; Mossa S; Mossa B
    Eur J Gynaecol Oncol; 2005; 26(5):485-90. PubMed ID: 16285562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy.
    van Dijck JA; Otten JD; Karssemeijer N; Kenemans P; Verbeek AL; van der Mooren MJ
    Climacteric; 2011 Dec; 14(6):683-8. PubMed ID: 21942620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammographic changes after hormone replacement therapy in patients who have undergone breast irradiation.
    Margolin FR; Denny SR; Gelfand CA; Jacobs RP
    AJR Am J Roentgenol; 1999 Jan; 172(1):147-50. PubMed ID: 9888757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal replacement therapy: mammographic manifestations.
    Berkowitz JE; Gatewood OM; Goldblum LE; Gayler BW
    Radiology; 1990 Jan; 174(1):199-201. PubMed ID: 2152982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A radiodiagnostic study of breast fibroadenoma.
    Rocek V; Holibková D; Köcher M; Vojácek K
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():227-39. PubMed ID: 2949499
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ultrasound mammography].
    Biedermann KJ; Tuma J
    Praxis (Bern 1994); 2001 May; 90(18):767-72. PubMed ID: 11392279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The meaning of mammographic breast density in users of postmenopausal hormone therapy.
    Speroff L
    Maturitas; 2002 Mar; 41(3):171-5. PubMed ID: 11886762
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk factors for Wolfe's dysplasia of mammograms in postmenopausal Turkish women.
    Uslu T; Topuz A; Erçal T; Acar B
    J Obstet Gynaecol (Tokyo 1995); 1995 Oct; 21(5):489-95. PubMed ID: 8542474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early diagnosis of breast carcinoma by mammographic demonstration of nonpalpable tumors].
    Dymarskiĭ LIu; Chernomordikova MF; Semiglazov VF; Popova RT
    Radiol Diagn (Berl); 1983; 24(2):181-7. PubMed ID: 6878661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.